Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$677M |
| 2 |
Tesla
TSLA
|
+$374M |
| 3 |
Constellation Brands
STZ
|
+$357M |
| 4 |
NVIDIA
NVDA
|
+$292M |
| 5 |
Meta Platforms (Facebook)
META
|
+$264M |
Top Sells
| 1 |
Netflix
NFLX
|
+$892M |
| 2 |
Charter Communications
CHTR
|
+$838M |
| 3 |
AbbVie
ABBV
|
+$553M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$488M |
| 5 |
FedEx
FDX
|
+$418M |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Consumer Discretionary | 17.73% |
| 3 | Financials | 13.26% |
| 4 | Healthcare | 11.95% |
| 5 | Communication Services | 11.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Apellis Pharmaceuticals
APLS
$3.33B
| $12.6M | 0.01% |
570,464
+191,313
| +50% | +$4.21M |
|
|
EQM
452
DELISTED
EQM Midstream Partners, LP
EQM
| $12.5M | 0.01% |
242,875
-44,817
| -16% | -$2.31M |
|
|
NFX
453
DELISTED
Newfield Exploration
NFX
| $12.1M | 0.01% |
+398,820
| New | +$12.1M |
|
454
G-III Apparel Group
GIII
$1.13B
| $12.1M | 0.01% |
271,525
+255,925
| +1,641% | +$11.4M |
|
455
Sunrun
RUN
$3.8B
| $12M | 0.01% |
910,842
-207,347
| -19% | -$2.73M |
|
|
NUVA
456
DELISTED
NuVasive, Inc.
NUVA
| $11.6M | 0.01% |
223,235
+15,197
| +7% | +$792K |
|
|
AIMT
457
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $11.6M | 0.01% |
429,534
+7,668
| +2% | +$206K |
|
|
IMGN
458
DELISTED
Immunogen Inc
IMGN
| $11.3M | 0.01% |
+1,164,643
| New | +$11.3M |
|
459
Reliance Steel & Aluminium
RS
$15.4B
| $11.3M | 0.01% |
129,246
-398,246
| -75% | -$34.9M |
|
460
AT&T
T
$209B
| $11.2M | 0.01% |
+460,118
| New | +$11.2M |
|
|
CIM
461
Chimera Investment
CIM
$1.18B
| $11M | 0.01% |
201,432
| – | – |
|
462
Warrior Met Coal
HCC
$3.07B
| $11M | 0.01% |
399,210
-136,307
| -25% | -$3.76M |
|
463
Select Water Solutions
WTTR
$928M
| $10.8M | 0.01% |
740,617
+177,241
| +31% | +$2.58M |
|
464
Wheaton Precious Metals
WPM
$47.9B
| $10.6M | 0.01% |
480,653
-28,518
| -6% | -$629K |
|
|
NSU
465
DELISTED
Nevsun Resources Ltd.
NSU
| $10.5M | 0.01% |
3,026,146
-288,446
| -9% | -$1M |
|
466
WSFS Financial
WSFS
$3.17B
| $10.3M | 0.01% |
192,473
+470
| +0.2% | +$25.1K |
|
|
KA
467
DELISTED
Kineta, Inc. Common Stock
KA
| $10.2M | 0.01% |
26,169
+299
| +1% | +$117K |
|
468
Adicet Bio
ACET
$67.8M
| $10.1M | 0.01% |
157,469
+40,961
| +35% | +$2.62M |
|
|
ANDX
469
DELISTED
Andeavor Logistics LP
ANDX
| $9.93M | 0.01% |
233,518
-274,567
| -54% | -$11.7M |
|
470
Repligen
RGEN
$6.74B
| $9.73M | 0.01% |
206,804
+182,562
| +753% | +$8.59M |
|
|
EVBG
471
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $9.68M | 0.01% |
+204,022
| New | +$9.68M |
|
|
DBD
472
DELISTED
Diebold Nixdorf Incorporated
DBD
| $9.61M | 0.01% |
804,554
-13,653
| -2% | -$163K |
|
473
iRhythm Technologies
IRTC
$5.85B
| $9.52M | 0.01% |
117,299
+5,262
| +5% | +$427K |
|
474
Lowe's Companies
LOW
$149B
| $9.41M | 0.01% |
+98,466
| New | +$9.41M |
|
475
Honeywell
HON
$134B
| $9.31M | 0.01% |
67,417
-141,943
| -68% | -$19.6M |
|